EPO Patents = 3

Forward Citations = 1

Loading Chart...

8 inventors (with patents filed for the assignee):

Woo Jin Park (6 out of 12 patents)

Tae Hwan Kwak (2 out of 8 patents)

Jae Gyun Oh (2 out of 3 patents)

4. Roger J Hajjar (1 out of 15 patents)

5. Dong Kwon Yang (1 out of 1 patent)

6. Pyoung Oh Yoon (1 out of 1 patent)

7. Seung Pil Jang (1 out of 1 patent)

8. Min-Ah Lee (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12215362 - Pharmaceutical composition for prevention or treatment of heart failure (2025-02-04),

2. 11761019 - Pharmaceutical composition for preventing or treating cardiac arrhythmia (2023-09-19),

3. 11426441 - Composition comprising protein phosphatase 1 inhibitory peptide for treating vascular diseases (2022-08-30),

4. RE48636 - Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban (2021-07-12),

5. 10479816 - Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban (2019-11-19),

6. 9855315 - Pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in a subject in need thereof (2018-01-02),

Company Overview

Bethphagen Inc. is a leading biotechnology company focused on developing innovative therapies for rare genetic disorders. With a team of dedicated scientists and researchers, Bethphagen is committed to improving the lives of patients by advancing cutting-edge treatments and technologies. Our mission is to bring hope and healing to those affected by rare diseases through groundbreaking research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#23 in Gwangju

#1,619 in South Korea

Gwangju, South Korea

Bethphagen Inc.

Forward Citations = 1

8 inventors:

Woo Jin Park (6 out of 12 patents)

Tae Hwan Kwak (2 out of 8 patents)

Jae Gyun Oh (2 out of 3 patents)

4. Roger J Hajjar (1 out of 15 patents)

5. Dong Kwon Yang (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bethphagen Inc.. Retrieved from https://idiyas.com/company/bethphagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]